SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM

被引：0

作者：

Cohen, Stanley B. ^{[1
]}

van Vollenhoven, Ronald ^{[2
]}

Winthrop, Kevin ^{[3
]}

Zerbini, Cristiano A. F. ^{[4
]}

Tanaka, Yoshiya ^{[5
]}

Bessette, Louis ^{[6
]}

Zhang, Ying ^{[7
]}

Khaff, Nasser ^{[7
]}

Hendrickson, Barbara ^{[7
]}

Enejosa, Jeffrey V. ^{[7
]}

Burmesters, Gerd ^{[8
]}

机构：

[1] Metroplex Clin Res Ctr, Dallas, TX USA

[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands

[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[4] Ctr Paulista Invest Clin, Sao Paulo, Brazil

[5] Univ Occupat & Environm Hlth, Kitakyushu, Japan

[6] Laval Univ, Quebec City, PQ, Canada

[7] AbbVie Inc, N Chicago, IL USA

[8] Charite, Berlin, Germany

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

118

引用

下载

页码：10 / 10

页数：1

共 50 条

[21] The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis
Yamaoka, Kunihiro
Tanaka, Yoshiya
Kameda, Hideto
Hendrickson, Barbara
Meerwein, Sebastian
Zhang, Ying
Takeuchi, Tsutomu
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[22] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Richez, C.
Lagunes-Galindo, I.
Liu, J.
Camp, H.
Song, Y.
Anyanwu, S.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 328 - 329
[23] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, Stanley B.
van Vollenhoven, Ronald
Curtis, Jeffrey R.
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Richez, Christophe
Lagunes-Galindo, Ivan
Liu, Jianzhong
Camp, Heidi S.
Song, Yanna
Anyanwu, Samuel I.
Burmester, Gerd R.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S105 - S105
[24] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI INADEQUATE RESPONDERS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
Fleischmann, Roy
Bessette, Louis
Hall, Stephen
Sparks, Jeffrey
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
RHEUMATOLOGY, 2023, 62
[25] Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis
Cohen, Stanley
Van Vollenhoven, Ronald F.
Curtis, Jeffrey
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Schlacher, Casey
Shaw, Tim
Liu, John
Enejosa, Jeffrey
Song, Yanna
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[26] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Schlacher, C.
Shaw, T.
Liu, J.
Enejosa, J. J.
Song, Y.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 315 - 316
[27] Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program
Peterfy, Charles G.
Strand, Vibeke
Friedman, Alan
Hall, Stephen
Mysler, Eduardo
Durez, Patrick
Baraliakos, Xenofon
Enejosa, Jeffrey, V
Shaw, Tim
Li, Yihan
Chen, Su
Song, In-Ho
RHEUMATOLOGY, 2022, 61 (08) : 3246 - 3256
[28] Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
Bykerk, V. P.
Cush, J.
Winthrop, K.
Calabrese, L.
Lortholary, O.
de Longueville, M.
van Vollenhoven, R.
Mariette, X.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 96 - 103
[29] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI-IR PATIENTS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
Fleischmann, R. M.
Bessette, L.
Sparks, J.
Hall, S.
Jain, M.
Kakehasi, A.
Song, Y.
Meerwein, S.
Demasi, R.
Suboticki, J.
Rubbert-Roth, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 618 - 619
[30] Efficacy and safety of upadacitinib in TNFi-IR patients with rheumatoid arthritis from three Phase 3 clinical trials
Fleischmann, Roy
Bessette, Louis
Sparks, Jeffrey
Hall, Stephen
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
SWISS MEDICAL WEEKLY, 2022, 152 : 14S - 16S

← 1 2 3 4 5 →